195 related articles for article (PubMed ID: 14567609)
1. Selective opening of the blood-tumor barrier by a nitric oxide donor and long-term survival in rats with C6 gliomas.
Weyerbrock A; Walbridge S; Pluta RM; Saavedra JE; Keefer LK; Oldfield EH
J Neurosurg; 2003 Oct; 99(4):728-37. PubMed ID: 14567609
[TBL] [Abstract][Full Text] [Related]
2. Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow.
Hiesiger EM; Voorhies RM; Basler GA; Lipschutz LE; Posner JB; Shapiro WR
Ann Neurol; 1986 Jan; 19(1):50-9. PubMed ID: 3080944
[TBL] [Abstract][Full Text] [Related]
3. Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors.
Nomura T; Inamura T; Black KL
Brain Res; 1994 Oct; 659(1-2):62-6. PubMed ID: 7529648
[TBL] [Abstract][Full Text] [Related]
4. Selective blood-tumor barrier disruption by leukotrienes.
Chio CC; Baba T; Black KL
J Neurosurg; 1992 Sep; 77(3):407-10. PubMed ID: 1506887
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
Shapiro WR; Voorhies RM; Hiesiger EM; Sher PB; Basler GA; Lipschutz LE
Cancer Res; 1988 Feb; 48(3):694-701. PubMed ID: 3335031
[TBL] [Abstract][Full Text] [Related]
6. Selective opening of the blood-tumor barrier by intracarotid infusion of leukotriene C4.
Black KL; King WA; Ikezaki K
J Neurosurg; 1990 Jun; 72(6):912-6. PubMed ID: 2338576
[TBL] [Abstract][Full Text] [Related]
7. [The effect on the tumor vessel permeability by hyperosmotic blood brain barrier disruption].
Miyagami M; Tazoe M; Kagawa Y; Tsubokawa T
No To Shinkei; 1988 Sep; 40(9):875-82. PubMed ID: 3142506
[TBL] [Abstract][Full Text] [Related]
8. Selective opening of the blood-tumour barrier by intracarotid infusion of leukotriene C4.
Black KL; King WA; Ikezaki K
Acta Neurochir Suppl (Wien); 1990; 51():140-1. PubMed ID: 1982476
[TBL] [Abstract][Full Text] [Related]
9. Quantitative autoradiographic measurements of blood-brain barrier permeability in the rat glioma model.
Yamada K; Ushio Y; Hayakawa T; Kato A; Yamada N; Mogami H
J Neurosurg; 1982 Sep; 57(3):394-8. PubMed ID: 7097336
[TBL] [Abstract][Full Text] [Related]
10. Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-π-activated nitric oxide donor PABA/NO in malignant gliomas.
Kogias E; Osterberg N; Baumer B; Psarras N; Koentges C; Papazoglou A; Saavedra JE; Keefer LK; Weyerbrock A
Int J Cancer; 2012 Mar; 130(5):1184-94. PubMed ID: 21455987
[TBL] [Abstract][Full Text] [Related]
11. Metabolically stable bradykinin B2 receptor agonists enhance transvascular drug delivery into malignant brain tumors by increasing drug half-life.
Sarin H; Kanevsky AS; Fung SH; Butman JA; Cox RW; Glen D; Reynolds R; Auh S
J Transl Med; 2009 May; 7():33. PubMed ID: 19439100
[TBL] [Abstract][Full Text] [Related]
12. [Regional blood flow of experimental brain tumors with special reference to effects of chemotherapy and radiotherapy].
Nagashima T; Matsutani M; Tamura A; Orii H
No To Shinkei; 1985 Mar; 37(3):287-94. PubMed ID: 3860212
[TBL] [Abstract][Full Text] [Related]
13. Temporal effects of dexamethasone on blood-to-brain and blood-to-tumor transport of 14C-alpha-aminoisobutyric acid in rat C6 glioma.
Shapiro WR; Hiesiger EM; Cooney GA; Basler GA; Lipschutz LE; Posner JB
J Neurooncol; 1990 Jun; 8(3):197-204. PubMed ID: 2358852
[TBL] [Abstract][Full Text] [Related]
14. Model for drug uptake by brain tumors: effects of osmotic treatment and of diffusion in brain.
Robinson PJ; Rapoport SI
J Cereb Blood Flow Metab; 1990 Mar; 10(2):153-61. PubMed ID: 2303532
[TBL] [Abstract][Full Text] [Related]
15. Effects of the nitric oxide donor JS-K on the blood-tumor barrier and on orthotopic U87 rat gliomas assessed by MRI.
Weidensteiner C; Reichardt W; Shami PJ; Saavedra JE; Keefer LK; Baumer B; Werres A; Jasinski R; Osterberg N; Weyerbrock A
Nitric Oxide; 2013 Apr; 30():17-25. PubMed ID: 23370169
[TBL] [Abstract][Full Text] [Related]
16. Hyperosmotic blood-brain barrier disruption in brains of rats with an intracerebrally transplanted RG-C6 tumor.
Inoue T; Fukui M; Nishio S; Kitamura K; Nagara H
J Neurosurg; 1987 Feb; 66(2):256-63. PubMed ID: 3100731
[TBL] [Abstract][Full Text] [Related]
17. Neoplastic and pharmacological influence on the permeability of an in vitro blood-brain barrier.
Grabb PA; Gilbert MR
J Neurosurg; 1995 Jun; 82(6):1053-8. PubMed ID: 7760177
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of malignant gliomas.
Krauseneck P; Müller B
Recent Results Cancer Res; 1994; 135():135-47. PubMed ID: 7519355
[No Abstract] [Full Text] [Related]
19. Regional blood flow and capillary permeability in the ethylnitrosourea-induced rat glioma.
Yamada K; Hayakawa T; Ushio Y; Arita N; Kato A; Mogami H
J Neurosurg; 1981 Dec; 55(6):922-8. PubMed ID: 7299466
[TBL] [Abstract][Full Text] [Related]
20. Increased opening of blood-tumour barrier by leukotriene C4 is dependent on size of molecules.
Black KL; Chio CC
Neurol Res; 1992 Dec; 14(5):402-4. PubMed ID: 1282688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
